Further to Azure Health Technology Limited's (NSX:VTL) announcement on 16 March 2021 that the first manufacturing run for our finished nutraceutical products has been completed.
Azure Health Technology Limited (NSX:VTL) trading as VGI Health Technology is pleased to announce that Pitt Street Research has issued an Initiation Report.
Azure Health Technology Limited trading as VGI Health Technology (NSX:VTL) is pleased to announce that an additional current Good Manufacturing Practice (cGMP) manufacturer has been appointed in the US.
Anatara Lifesciences (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in humans and animals is pleased to provide this update on clinical trial activities.
iQX Limited (iQX Ltd) (NSX:IQX) would like to announce that Life Science Biosensor Diagnostics Pty Ltd (LSBD) in which iQX Ltd holds a 19% equity position, has received approval from the Harvard Longwood campus Institutional Review Board (IRB) to commence a clinical validation study to test patient samples from a COVID-19 repository.
Anatara Lifesciences (ASX:ANR), a developer of non-antibiotic oral solutions for gastrointestinal diseases in animals and humans, is pleased to provide this activities report for the quarter ending 31 March 2021, along with the Company's Appendix 4C cash flow report.
Anatara Lifesciences (ASX:ANR) is pleased to advise that it is has received Human Research Ethics Committee (HREC) approval to undertake a clinical trial on the effects of 3FDC dietary supplementation on psychological functioning in an adult population.
